Ronald Blue Trust, Inc. Cardlytics, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.21 Billion
- Q2 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Cardlytics, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 384 shares of CDLX stock, worth $1,317. This represents 0.0% of its overall portfolio holdings.
Number of Shares
384Holding current value
$1,317% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding CDLX
# of Institutions
146Shares Held
33.8MCall Options Held
946KPut Options Held
1.01M-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.46MShares$22.2 Million4.15% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$8.28 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.17MShares$7.43 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.1MShares$7.2 Million1.57% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $113M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...